Cargando…
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants
Serum titers of SARS-CoV-2 neutralizing antibodies (nAb) correlate well with protection from symptomatic COVID-19, but decay rapidly in the months following vaccination or infection. In contrast, measles-protective nAb titers are life-long after measles vaccination, possibly due to persistence of th...
Autores principales: | Muñoz-Alía, Miguel Á., Nace, Rebecca A., Balakrishnan, Baskar, Zhang, Lianwen, Packiriswamy, Nandakumar, Singh, Gagandeep, Warang, Prajakta, Mena, Ignacio, Narjari, Riya, Vandergaast, Rianna, García-Sastre, Adolfo, Schotsaert, Michael, Russell, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774211/ https://www.ncbi.nlm.nih.gov/pubmed/36561187 http://dx.doi.org/10.1101/2022.12.16.520799 |
Ejemplares similares
-
MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum
por: Muñoz-Alía, Miguel Ángel, et al.
Publicado: (2021) -
Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins
por: Muñoz-Alía, Miguel Ángel, et al.
Publicado: (2021) -
Seroprevalence of Measles Antibodies and Predictors for Seropositivity among Chinese Children
por: Wang, Xiaoqin, et al.
Publicado: (2017) -
Measles or Not Measles? That Is the Question!
por: Ibraheim, Marina Kristy, et al.
Publicado: (2020) -
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine
por: Peng, Kah-Whye, et al.
Publicado: (2022)